Michael L Merchant1, Michelle T Barati2, Dawn J Caster2, Jessica L Hata3, Liliane Hobeika4, Susan Coventry3, Michael E Brier2, Daniel W Wilkey2, Ming Li2, Ilse M Rood5, Jeroen K Deegens5, Jack F Wetzels5, Christopher P Larsen6, Jonathan P Troost7, Jeffrey B Hodgin8, Laura H Mariani9, Matthias Kretzler9, Jon B Klein2,10, Kenneth R McLeish1. 1. Division of Nephrology and Hypertension, Department of Medicine, University of Louisville, Louisville, Kentucky k.mcleish@louisville.edu michael.merchant@louisville.edu. 2. Division of Nephrology and Hypertension, Department of Medicine, University of Louisville, Louisville, Kentucky. 3. Pathology Department, Norton Children's Hospital, Louisville, Kentucky. 4. Division of Nephrology, Department of Medicine, Temple University, Philadelphia, Pennsylvania. 5. Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands. 6. Arkana Laboratories, Little Rock, Arkansas. 7. Michigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor, Michigan. 8. Division of Pathology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. 9. Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. 10. Robley Rex Veterans Affairs Medical Center, Louisville, Kentucky.
Abstract
BACKGROUND: The mechanisms leading to extracellular matrix (ECM) replacement of areas of glomerular capillaries in histologic variants of FSGS are unknown. This study used proteomics to test the hypothesis that glomerular ECM composition in collapsing FSGS (cFSGS) differs from that of other variants. METHODS: ECM proteins in glomeruli from biopsy specimens of patients with FSGS not otherwise specified (FSGS-NOS) or cFSGS and from normal controls were distinguished and quantified using mass spectrometry, verified and localized using immunohistochemistry (IHC) and confocal microscopy, and assessed for gene expression. The analysis also quantified urinary excretion of ECM proteins and peptides. RESULTS: Of 58 ECM proteins that differed in abundance between cFSGS and FSGS-NOS, 41 were more abundant in cFSGS and 17 in FSGS-NOS. IHC showed that glomerular tuft staining for cathepsin B, cathepsin C, and annexin A3 in cFSGS was significantly greater than in other FSGS variants, in minimal change disease, or in membranous nephropathy. Annexin A3 colocalized with cathepsin B and C, claudin-1, phosphorylated ERK1/2, and CD44, but not with synaptopodin, in parietal epithelial cells (PECs) infiltrating cFSGS glomeruli. Transcripts for cathepsins B and C were increased in FSGS glomeruli compared with normal controls, and urinary excretion of both cathepsins was significantly greater in cFSGS compared with FSGS-NOS. Urinary excretion of ECM-derived peptides was enhanced in cFSGS, although in silico analysis did not identify enhanced excretion of peptides derived from cathepsin B or C. CONCLUSIONS: ECM differences suggest that glomerular sclerosis in cFSGS differs from that in other FSGS variants. Infiltration of activated PECs may disrupt ECM remodeling in cFSGS. These cells and their cathepsins may be therapeutic targets.
BACKGROUND: The mechanisms leading to extracellular matrix (ECM) replacement of areas of glomerular capillaries in histologic variants of FSGS are unknown. This study used proteomics to test the hypothesis that glomerular ECM composition in collapsing FSGS (cFSGS) differs from that of other variants. METHODS: ECM proteins in glomeruli from biopsy specimens of patients with FSGS not otherwise specified (FSGS-NOS) or cFSGS and from normal controls were distinguished and quantified using mass spectrometry, verified and localized using immunohistochemistry (IHC) and confocal microscopy, and assessed for gene expression. The analysis also quantified urinary excretion of ECM proteins and peptides. RESULTS: Of 58 ECM proteins that differed in abundance between cFSGS and FSGS-NOS, 41 were more abundant in cFSGS and 17 in FSGS-NOS. IHC showed that glomerular tuft staining for cathepsin B, cathepsin C, and annexin A3 in cFSGS was significantly greater than in other FSGS variants, in minimal change disease, or in membranous nephropathy. Annexin A3 colocalized with cathepsin B and C, claudin-1, phosphorylated ERK1/2, and CD44, but not with synaptopodin, in parietal epithelial cells (PECs) infiltrating cFSGS glomeruli. Transcripts for cathepsins B and C were increased in FSGS glomeruli compared with normal controls, and urinary excretion of both cathepsins was significantly greater in cFSGS compared with FSGS-NOS. Urinary excretion of ECM-derived peptides was enhanced in cFSGS, although in silico analysis did not identify enhanced excretion of peptides derived from cathepsin B or C. CONCLUSIONS: ECM differences suggest that glomerular sclerosis in cFSGS differs from that in other FSGS variants. Infiltration of activated PECs may disrupt ECM remodeling in cFSGS. These cells and their cathepsins may be therapeutic targets.
Authors: Jennifer Eymael; Shagun Sharma; Markus A Loeven; Jack F Wetzels; Fieke Mooren; Sandrine Florquin; Jeroen K Deegens; Brigith K Willemsen; Vikram Sharma; Toin H van Kuppevelt; Marinka A Bakker; Tammo Ostendorf; Marcus J Moeller; Henry B Dijkman; Bart Smeets; Johan van der Vlag Journal: Kidney Int Date: 2017-12-21 Impact factor: 10.612
Authors: John J Sim; Simran K Bhandari; Michael Batech; Aviv Hever; Teresa N Harrison; Yu-Hsiang Shu; Dean A Kujubu; Tracy Y Jonelis; Michael H Kanter; Steven J Jacobsen Journal: Mayo Clin Proc Date: 2018-01-24 Impact factor: 7.616
Authors: Michael L Merchant; Bruce A Perkins; Grzegorz M Boratyn; Linda H Ficociello; Daniel W Wilkey; Michelle T Barati; Clinton C Bertram; Grier P Page; Brad H Rovin; James H Warram; Andrzej S Krolewski; Jon B Klein Journal: J Am Soc Nephrol Date: 2009-07-30 Impact factor: 10.121
Authors: Matthew W Parker; Daniel Rossi; Mark Peterson; Karen Smith; Kristina Sikström; Eric S White; John E Connett; Craig A Henke; Ola Larsson; Peter B Bitterman Journal: J Clin Invest Date: 2014-03-03 Impact factor: 14.808
Authors: Michael R Bennett; Kimberly A Czech; Lois J Arend; David P Witte; Prasad Devarajan; S Steven Potter Journal: Nephron Exp Nephrol Date: 2007-08-06
Authors: Bart Smeets; Fabien Stucker; Jack Wetzels; Isabelle Brocheriou; Pierre Ronco; Hermann-Josef Gröne; Vivette D'Agati; Agnes B Fogo; Toin H van Kuppevelt; Hans-Peter Fischer; Peter Boor; Jürgen Floege; Tammo Ostendorf; Marcus J Moeller Journal: Am J Pathol Date: 2014-10-07 Impact factor: 4.307
Authors: Crystal A Gadegbeku; Debbie S Gipson; Lawrence B Holzman; Akinlolu O Ojo; Peter X K Song; Laura Barisoni; Matthew G Sampson; Jeffrey B Kopp; Kevin V Lemley; Peter J Nelson; Chrysta C Lienczewski; Sharon G Adler; Gerald B Appel; Daniel C Cattran; Michael J Choi; Gabriel Contreras; Katherine M Dell; Fernando C Fervenza; Keisha L Gibson; Larry A Greenbaum; Joel D Hernandez; Stephen M Hewitt; Sangeeta R Hingorani; Michelle Hladunewich; Marie C Hogan; Susan L Hogan; Frederick J Kaskel; John C Lieske; Kevin E C Meyers; Patrick H Nachman; Cynthia C Nast; Alicia M Neu; Heather N Reich; John R Sedor; Christine B Sethna; Howard Trachtman; Katherine R Tuttle; Olga Zhdanova; Gastòn E Zilleruelo; Matthias Kretzler Journal: Kidney Int Date: 2013-01-16 Impact factor: 10.612
Authors: Andrea L Oliverio; Dorota Marchel; Jonathan P Troost; Isabelle Ayoub; Salem Almaani; Jessica Greco; Cheryl L Tran; Michelle R Denburg; Michael Matheny; Chad Dorn; Susan F Massengill; Hailey Desmond; Debbie S Gipson; Laura H Mariani Journal: Kidney360 Date: 2021-09-27
Authors: Kelly D Smith; David K Prince; Kammi J Henriksen; Roberto F Nicosia; Charles E Alpers; Shreeram Akilesh Journal: Kidney Int Date: 2022-02-26 Impact factor: 18.998
Authors: Timothy D Cummins; Erik A Korte; Sagar Bhayana; Michael L Merchant; Michelle T Barati; William E Smoyer; Jon B Klein Journal: Pediatr Nephrol Date: 2022-02-26 Impact factor: 3.651
Authors: Laith Farah Al-Rabadi; Tiffany Caza; Claire Trivin-Avillach; Aylin R Rodan; Nicole Andeen; Norifumi Hayashi; Brandi Williams; Monica P Revelo; Fred Clayton; Jo Abraham; Edwin Lin; Willisa Liou; Chang-Jiang Zou; Nirupama Ramkumar; Tim Cummins; Daniel W Wilkey; Issa Kawalit; Christian Herzog; Aaron Storey; Rick Edmondson; Ronald Sjoberg; Tianxin Yang; Jeremy Chien; Michael Merchant; John Arthur; Jon Klein; Chris Larsen; Laurence H Beck Journal: J Am Soc Nephrol Date: 2021-05-05 Impact factor: 14.978
Authors: Sarah N Lipp; Kathryn R Jacobson; David S Hains; Andrew L Schwarderer; Sarah Calve Journal: J Am Soc Nephrol Date: 2021-04-19 Impact factor: 14.978
Authors: Fatih Demir; Anne Troldborg; Steffen Thiel; Moritz Lassé; Pitter F Huesgen; Nicola M Tomas; Thorsten Wiech; Markus M Rinschen Journal: Cell Tissue Res Date: 2021-04-17 Impact factor: 4.051
Authors: Michael Randles; Franziska Lausecker; Qing Kong; Hani Suleiman; Graeme Reid; Maria Kolatsi-Joannou; Pinyuan Tian; Sara Falcone; Bernard Davenport; Paul Potter; Tom Van Agtmael; Jill Norman; David Long; Martin Humphries; Jeffrey Miner; Rachel Lennon Journal: J Am Soc Nephrol Date: 2021-05-28 Impact factor: 14.978